Welcome to the international HTA database

Showing [21959 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2018	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Vagus nerve stimulation for chronic major depressive episodes
2018	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Human tissue (topical) wound treatments - ulcers and burns (EpiFix and EpiBurn)
2018	NIHR Health Technology Assessment programme	Structured lifestyle education to support weight loss for people with schizophrenia, schizoaffective disorder and first episode psychosis: the STEPWISE RCT
2018	NIHR Health Technology Assessment programme	Combining optical coherence tomography with visual field data to rapidly detect disease progression in glaucoma: a diagnostic accuracy study
2018	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Emicizumab for routine prophylaxis to prevent bleeding or reduce the frequency of bleeding episodes in patients with Haemophilia A (congenital Factor VIII deficiency) with or without Factor VIII inhibitors
2018	NIHR Health Technology Assessment programme	The future for diagnostic tests of acute kidney injury in critical care: evidence synthesis, care pathway analysis and research prioritisation
2018	Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU)	[Psychological treatments and psychosocial interventions in forensic psychiatry – a systematic review]
2018	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Human tissue (surgical) wound treatments - laminectomy and tendon repair (AmnioFix, AmnioWrap and AmnioFix Injectable)
2018	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Purified human alpha1-proteinase inhibitor (A1-P1) for the treatment of alpha1-proteinase inhibitor deficiency, leading to chronic obstructive pulmonary disease
2018	Penn Medicine Center for Evidence-based Practice (CEP)	Acid Suppression Therapy for Oncology Patients
2018	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Endoscopic placement and removal of an intra-gastric balloon (IGB) for the management of overweight and obesity, in a high-risk patient
2018	NIHR Health Technology Assessment programme	Selecting pregnant or postpartum women with suspected pulmonary embolism for diagnostic imaging: the DiPEP diagnostic study with decision-analysis modelling
2018	Health Technology Wales (HTW)	Mechanical chest compression for use by the ambulance service to treat adults with out-of-hospital non-traumatic cardiac arrest
2018	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Vagus nerve stimulation for chronic major depressive episodes
2018	European Network for Health Technology Assessment (EUnetHTA)	Alectinib (Alecensa©) as monotherapy for the first line treatment of adult patients with ALK-positive advanced non-small cell lung cancer (NSCLC)
2018	Belgian Health Care Knowledge Centre (KCE)	Responsible use of high-risk medical devices: the example of 3D printed medical devices
2018	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	New item numbers and rebates for mobile radiology services
2018	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Purified human alpha1-proteinase inhibitor (A1-P1) for the treatment of alpha1-proteinase inhibitor deficiency, leading to chronic obstructive pulmonary disease (COPD)
2018	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Invitation and decision aid for cervical cancer screening]
2018	Health Technology Wales (HTW)	Faecal immunochemical test-based prediction tools for the assessment of people presenting to primary care with symptomatic bowel disease
2018	Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU)	[Scientific evidence and evidence gaps in social work assessments and interventions for persons receiving social assistance or their families]
2018	European Network for Health Technology Assessment (EUnetHTA)	Screening of fetal trisomies 21, 18 and 13 by non invasive prenatal testing
2018	Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU)	[Organisational models for securing access to health and dental care services for children in out-of-home care]
2018	European Network for Health Technology Assessment (EUnetHTA)	MammaPrint® – added value of using the gene expression signature test MammaPrint® for adjuvant chemotherapy decision-making in early breast cancer
2018	Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU)	[Endometriosis – Diagnosis, treatment and patient experiences]
2018	European Network for Health Technology Assessment (EUnetHTA)	Transcatheter aortic valve implantation (TAVI) in patients at intermediate surgical risk
2018	European Network for Health Technology Assessment (EUnetHTA)	Femtosecond laser-assisted cataract surgery (FLACS) for the treatment of age-related cataract
2018	NIHR Health Technology Assessment programme	A longitudinal national evaluation of Schwartz Centre Rounds: an intervention to enhance compassion in relationships between staff and patients through providing support for staff and promoting their wellbeing
2018	European Network for Health Technology Assessment (EUnetHTA)	Continuous glucose monitoring (CGM real-time) and flash glucose monitoring (FGM) as personal, standalone systems in patients with diabetes mellitus treated with insulin
2018	NIHR Health Technology Assessment programme	An evaluation of a real-time survey for improving patients' experiences of the relational aspects of care
2018	National Authority for Assessment and Accreditation in Healthcare (INEAS)	Le trastuzumab dans le traitement du cancer du sein HER2 positif au stade précoce et localement avancé
2018	European Network for Health Technology Assessment (EUnetHTA)	High-intensity focused ultrasound (HIFU) ablation for the treatment of prostate cancer
2018	Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU)	[Primary care interventions provided to families where children have been subjected to abuse and neglect]
2018	Health Quality Ontario (HQO)	Internet-Delivered Cognitive Behavioural Therapy for Major Depression and Anxiety Disorders: A Health Technology Assessment
2018	Health Quality Ontario (HQO)	Remote Monitoring of Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy and Permanent Pacemakers: A Health Technology Assessment
2018	European Network for Health Technology Assessment (EUnetHTA)	Custom-made or customisable 3D printed implants and cutting guides versus non-3D printed standard implants and cutting guides for improving outcome in patients undergoing knee, maxillofacial, or cranial surgery
2018	Health Quality Ontario (HQO)	Magnetic Resonance-Guided Focused Ultrasound Neurosurgery for Essential Tremor: A Health Technology Assessment
2018	Health Quality Ontario (HQO)	Structured Education and Neuromuscular Exercise Program for Hip and/or Knee Osteoarthritis: A Health Technology Assessment
2018	Adelaide Health Technology Assessment (AHTA)	Systematic literature review on the association between alcohol consumption and mental health disorders. Technical Report
2018	NIHR Health Technology Assessment programme	Amaze: a double-blind, multicentre randomised controlled trial to investigate the clinical effectiveness and cost-effectiveness of adding an ablation device-based maze procedure as an adjunct to routine cardiac surgery for patients with pre-existing atrial fibrillation
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Nusinersen in spinal muscular atrophy]
2018	Health Quality Ontario (HQO)	Electronic Monitoring Systems to Assess Urinary Incontinence: A Health Technology Assessment
2018	NIHR Health Technology Assessment programme	Routine low-dose continuous or nocturnal oxygen for people with acute stroke: three-arm Stroke Oxygen Supplementation RCT
2018	NIHR Health Technology Assessment programme	AntiEpileptic drug Monitoring in PREgnancy (EMPiRE): a double-blind randomised trial on effectiveness and acceptability of monitoring strategies
2018	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Meniscal allograft transplantation for post-meniscectomy syndrome
2018	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Telemonitoring using active cardiac implantable devices in ventricular tachyarrhythmia and heart failure]
2018	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Support for the development of an S3 guideline on natural childbirth - Evidence reports]
2018	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Obinutuzumab (non-pretreated advanced follicular lymphoma) - Assessment according to §35a (1), Sentence 11, Social Code Book V]
2018	NIHR Health Technology Assessment programme	Positive behaviour support training for staff for treating challenging behaviour in people with intellectual disabilities: a cluster RCT
2018	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Midostaurin (acute myeloid leukaemia) - Assessment according to §35a (1), Sentence 11, Social Code Book V]
2018	NIHR Health Technology Assessment programme	The UK EndoVascular Aneurysm Repair (EVAR) randomised controlled trials: long-term follow-up and cost-effectiveness analysis
2018	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Telotristat ethyl (carcinoid syndrome diarrhoea) - Benefit assessment according to §35a (1), Sentence 11, Social Code Book V]
2018	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Sofosbuvir (hepatitis C in adolescents) - Benefit assessment according to §35a Social Code Book V]
2018	Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)	[Evaluation of ambulatory electrocardiography technologies for the diagnosis of cardiac arrhythmia]
2018	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Cabozantinib (renal cell carcinoma) - Benefit assessment according to §35a Social Code Book V]
2018	Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)	[Evaluation of the ultrasonic flowmeter for verification of graft patency during coronary artery bypass grafting]
2018	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Echocardiography: Guideline recommendations and options to identify inappropriate use as well as usage rate in Austria
2018	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Sofosbuvir/velpatasvir/voxilaprevir (chronic hepatitis C) - Addendum to Commission A17-35]
2018	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Stem cell treatments within surgical specialities: what is the evidence?
2018	NIHR Health Technology Assessment programme	Triple versus guideline antiplatelet therapy to prevent recurrence after acute ischaemic stroke or transient ischaemic attack: the TARDIS RCT
2018	Basque Office for Health Technology Assessment (OSTEBA)	[HIFU —High intensity focused ultrasound— in essential tremor]
2018	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Brodalumab (plaque psoriasis) - Addendum to Commission A17-42]
2018	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Leaving surgical training: some of the reasons are in surgery
2018	Basque Office for Health Technology Assessment (OSTEBA)	[Evaluation of the scientific evidence on nipple-areola complex micropigmentation, requirements for its proper implementation and costs]
2018	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Carfilzomib (multiple myeloma) - Addendum to Commission A17-38]
2018	Basque Office for Health Technology Assessment (OSTEBA)	[Immunological faecal occult blood test for patients with symptoms compatible with colorectal cancer: recommendation of Clinical Practice Guides and use in the National Health System]
2018	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Daratumumab (multiple myeloma) - Addendum to Commission A17-40]
2018	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Day case hernia repair: weak evidence or practice gap?
2018	NIHR Health Technology Assessment programme	Therapeutic hypothermia to reduce intracranial pressure after traumatic brain injury: the Eurotherm3235 RCT
2018	Basque Office for Health Technology Assessment (OSTEBA)	[Radiofrequency tonsil reduction]
2018	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Nonacog beta pegol (haemophilia B) - Benefit assessment according to §35a Social Code Book V]
2018	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Prostate artery embolisation: poor design and reporting impact the value of current systematic reviews
2018	NIHR Health Technology Assessment programme	Strategy of endovascular versus open repair for patients with clinical diagnosis of ruptured abdominal aortic aneurysm: the IMPROVE RCT
2018	NIHR Health Services and Delivery Research programme	NHS managers' use of nursing workforce planning and deployment technologies: a realist synthesis of implementation and impact
2018	Basque Office for Health Technology Assessment (OSTEBA)	[Effectiveness and safety of bone suppression technology for the detection of lung cancer and indications for its use]
2018	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Tivozanib (renal cell carcinoma) - Benefit assessment according to §35a Social Code Book V]
2018	NIHR Health Technology Assessment programme	PET-PANC: multicentre prospective diagnostic accuracy and health economic analysis study of the impact of combined modality 18fluorine-2-fluoro-2-deoxy-d-glucose positron emission tomography with computed tomography scanning in the diagnosis and management of pancreatic cancer
2018	Basque Office for Health Technology Assessment (OSTEBA)	[Strategies for promoting and strengthening evidence-based nursing in the Basque Country]
2018	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Search for guidelines for the update of the DMP "coronary heart disease"]
2018	Belgian Health Care Knowledge Centre (KCE)	MammaPrint® test for personalised management of adjuvant chemotherapy decisions in early breast cancer
2018	Basque Office for Health Technology Assessment (OSTEBA)	[Checklist for ethical and legal domains analysis]
2018	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Support for the development of an S3 guideline on natural childbirth - Evidence reports]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Phlebotonics for venous insufficiency]
2018	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Cenegermin (moderate or severe neurotrophic keratitis) - Benefit assessment according to §35a (1), Sentence 11, Social Code Book V]
2018	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Pulsed electromagnetic fields for bone healing disorders]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Endometrial receptivity array in assisted reproduction]
2018	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Ribociclib (breast cancer) - Addendum to Commission A17-45]
2018	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Pulsed electromagnetic fields for bone healing disorders - Addendum to Commission E17-08]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[High altitude simulation test for patients with lung disease]
2018	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Elvitegravir/cobicistat/emtricitabine/ tenofovir disoproxil (HIV-1 in adolescents) - Benefit assessment according to §35a Social Code Book (SGB) V]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Radiofrequency percutaneous nucleoplasty in disc disorders]
2018	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Atezolizumab (non-small cell lung cancer) - Addendum to A17-50]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Thioridazine for the treatment of behavior disorders in patients with intellectual disability]
2018	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Perampanel (epilepsy) - Benefit assessment according to §35a Social Code Book (SGB) V]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Pomalidomide combined with dexamethasone in multiple myeloma]
2018	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Guselkumab (plaque psoriasis) - Benefit assessment according to §35a Social Code Book V]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Fetoscopic laser photocoagulation in twin-twin transfusion syndrome]
2018	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Cladribine (multiple sclerosis) - Benefit assessment according to §35a Social Code Book (SGB) V]
2018	Institute for Clinical Effectiveness and Health Policy (IECS)	[Daratumumab for relapsed or refractory multiple myeloma]
2018	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Dupilumab (atopic dermatitis) - Benefit assessment according to §35a Social Code Book (SGB) V]